{
    "clinical_study": {
        "@rank": "33395", 
        "arm_group": [
            {
                "arm_group_label": "Allergic group", 
                "description": "All patients who used Reduning Injection have anaphylaxis."
            }, 
            {
                "arm_group_label": "Control group", 
                "description": "All patients who used Reduning Injection don't have anaphylaxis.One allergic group patient should matched four control group patients."
            }
        ], 
        "brief_summary": {
            "textblock": "This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy\n      of Chinese Medical Sciences in January 2013.\n\n      The purpose of this study is to make a event monitoring to see whether Reduning injection is\n      safe and the characteristic and mechanism of anaphylactic reaction used Reduning injection\n      in hospitals in China."
        }, 
        "brief_title": "A Registry Study on Reduning\uff08a Chinese Medicine Injection\uff09Used in Hospitals in China", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Upper Respiratory Tract Infection;", 
            "Acute Tracheobronchitis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anaphylaxis", 
                "Respiratory Tract Infections", 
                "Bronchitis", 
                "Acute Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "It is very common that Chinese Medicine Injection used in hospitals in mainland China.\n      However safety problems rose in recent years. There could be many uncertain factors\n      influence Chinese Medicine Injection in clinical practice.\n\n      In order to ensure the safety of public drug use and lower drug-induced risks, a registry\n      study for Reduning injection safety surveillance with 3000 patients will be conducted from\n      Jan.2013 to Mar.2013.At the same time,Patients who have anaphylactic reaction are selected\n      as the allergic group and not have anaphylactic reaction are selected as the control\n      group.The proportion of allergic group and control group is 1:4.All the patients who are\n      selected should draw blood.\n\n      Eligibility criteria Patients who will use Reduning injection in selected hospitals."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients using Reduning injection from January to March 2013\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "1 Month", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "An anticipated sample size was caculated in this study, about 3000 Patients using Reduning\n        injection from January to March 2013 in hospitals."
            }
        }, 
        "enrollment": {
            "#text": "3000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824719", 
            "org_study_id": "200907001-5-6-1"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 2, 2013", 
        "location": {
            "contact": {
                "email": "studentjiangjunjie@tom.com", 
                "last_name": "Jiang J Jie", 
                "phone": "010-64014411", 
                "phone_ext": "2802"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100700"
                }, 
                "name": "Institute of Basic Research in Clinical Medicine"
            }, 
            "investigator": {
                "last_name": "Xie M Yan, BA", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "a Study of Clinical Safety Monitoring and the Mechanism of Anaphylactic Reaction Used Reduning(a Chinese Medicine Injection)in Hospitals in China", 
        "overall_official": {
            "affiliation": "China  Academy of Chinese Medical Sciences", 
            "last_name": "Xie Y Ming", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: State Administration of Traditional Chinese Medicine of the People's Republic of China", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of participants with anaphylactic reaction;the blood routine examination of participants with anaphylactic reaction", 
            "safety_issue": "Yes", 
            "time_frame": "to assess Reduning's 'anaphylactic reaction' .during patients' hospital stay, administration information of Reduning will be registered every day. The registry procedure will last 3 month only for patients using Reduning"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824719"
        }, 
        "responsible_party": {
            "investigator_affiliation": "China  Academy of Chinese Medical Sciences", 
            "investigator_full_name": "Yanming Xie", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "China  Academy of Chinese Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "China  Academy of Chinese Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "15 Days", 
        "verification_date": "April 2013"
    }
}